Literature DB >> 14684699

Mutation screening of Mre11 complex genes: indication of RAD50 involvement in breast and ovarian cancer susceptibility.

K Heikkinen, S-M Karppinen, Y Soini, M Mäkinen, R Winqvist.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 14684699      PMCID： PMC1735331          DOI： 10.1136/jmg.40.12.e131

Source DB:  PubMed          Journal:  J Med Genet        ISSN： 0022-2593            Impact factor:   6.318


× No keyword cloud information.
  40 in total

1.  Transcriptome-guided characterization of genomic rearrangements in a breast cancer cell line.

Authors:  Qi Zhao; Otavia L Caballero; Samuel Levy; Brian J Stevenson; Christian Iseli; Sandro J de Souza; Pedro A Galante; Dana Busam; Margaret A Leversha; Kalyani Chadalavada; Yu-Hui Rogers; J Craig Venter; Andrew J G Simpson; Robert L Strausberg
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-30       Impact factor: 11.205

Review 2.  Familial/inherited cancer syndrome: a focus on the highly consanguineous Arab population.

Authors:  Fawz S AlHarthi; Alya Qari; Alaa Edress; Malak Abedalthagafi
Journal:  NPJ Genom Med       Date:  2020-02-03       Impact factor: 8.617

Review 3.  DNA repair dysregulation from cancer driver to therapeutic target.

Authors:  Nicola J Curtin
Journal:  Nat Rev Cancer       Date:  2012-12       Impact factor: 60.716

4.  Mutation screening of RAD51C in high-risk breast and ovarian cancer families.

Authors:  Wenping Lu; Xianshu Wang; Hongsheng Lin; Noralane M Lindor; Fergus J Couch
Journal:  Fam Cancer       Date:  2012-09       Impact factor: 2.375

Review 5.  Next-generation sequencing for inherited breast cancer risk: counseling through the complexity.

Authors:  Irene R Rainville; Huma Q Rana
Journal:  Curr Oncol Rep       Date:  2014-03       Impact factor: 5.075

Review 6.  Growing recognition of the role for rare missense substitutions in breast cancer susceptibility.

Authors:  Sean V Tavtigian; Georgia Chenevix-Trench
Journal:  Biomark Med       Date:  2014       Impact factor: 2.851

7.  Comprehensive Transcriptome and Mutational Profiling of Endemic Burkitt Lymphoma Reveals EBV Type-Specific Differences.

Authors:  Yasin Kaymaz; Cliff I Oduor; Hongbo Yu; Juliana A Otieno; John Michael Ong'echa; Ann M Moormann; Jeffrey A Bailey
Journal:  Mol Cancer Res       Date:  2017-05       Impact factor: 5.852

8.  DNA repair genes implicated in triple negative familial non-BRCA1/2 breast cancer predisposition.

Authors:  Marie Ollier; Nina Radosevic-Robin; Fabrice Kwiatkowski; Flora Ponelle; Sandrine Viala; Maud Privat; Nancy Uhrhammer; Dominique Bernard-Gallon; Frédérique Penault-Llorca; Yves-Jean Bignon; Yannick Bidet
Journal:  Am J Cancer Res       Date:  2015-06-15       Impact factor: 6.166

Review 9.  Inhibiting the DNA damage response as a therapeutic manoeuvre in cancer.

Authors:  N J Curtin
Journal:  Br J Pharmacol       Date:  2013-08       Impact factor: 8.739

10.  Genetic variation in the NBS1, MRE11, RAD50 and BLM genes and susceptibility to non-Hodgkin lymphoma.

Authors:  Johanna M Schuetz; Amy C MaCarthur; Stephen Leach; Agnes S Lai; Richard P Gallagher; Joseph M Connors; Randy D Gascoyne; John J Spinelli; Angela R Brooks-Wilson
Journal:  BMC Med Genet       Date:  2009-11-16       Impact factor: 2.103
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.